Patents by Inventor Eric Stec

Eric Stec has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TRANSGLUTAMINASE TREATED PRODUCTS
    Publication number: 20230364300
    Abstract: The present application relates to use of transglutaminases to treat various products, including medical devices such as tissue grafts, tissue matrices or other tissue-derived materials, and synthetics. The transglutaminases can be applied to the medical devices to provide advantages such as adhesion resistance or abrasion resistance.
    Type: Application
    Filed: July 24, 2023
    Publication date: November 16, 2023
    Inventors: Yi Chen, Sean Collins, Li Ting Huang, Eric Stec, Hui Xu
  • Transglutaminase treated products
    Patent number: 11724004
    Abstract: The present application relates to use of transglutaminases to treat various products, including medical devices such as tissue grafts, tissue matrices or other tissue-derived materials, and synthetics. The transglutaminases can be applied to the medical devices to provide advantages such as adhesion resistance or abrasion resistance.
    Type: Grant
    Filed: October 6, 2020
    Date of Patent: August 15, 2023
    Assignee: LifeCell Corporation
    Inventors: Yi Chen, Sean Collins, Li Ting Huang, Eric Stec, Hui Xu
  • DEVICES INCLUDING MUSCLE MATRIX AND METHODS OF PRODUCTION AND USE
    Publication number: 20220062502
    Abstract: Tissue compositions and methods of preparation thereof are provided. The tissue compositions can be used to treat or regenerate muscle tissue. The compositions can be configured to provide increased strength compared to other muscle matrices.
    Type: Application
    Filed: September 6, 2021
    Publication date: March 3, 2022
    Inventors: Li Ting Huang, Eric Stec, Nathaniel Bachrach, Hui Xu
  • TISSUE MATRIX MATERIALS AND ENZYMATIC ADHESIVES
    Publication number: 20210290735
    Abstract: The present application relates to use of transglutaminases to treat various tissue matrix products. The methods can include application of a transglutaminase to a partially denatured collagen-containing tissue matrix and implantation of the tissue matrix. The transglutaminase can facilitate adhesion with another collagen-containing tissue matrix, tissue surrounding the tissue matrix after implantation, or both.
    Type: Application
    Filed: February 2, 2021
    Publication date: September 23, 2021
    Inventors: Eric Stec, Ming F. Pomerleau, Rick T. Owens, Richard Seeman
  • Devices including muscle matrix and methods of production and use
    Patent number: 11110201
    Abstract: Tissue compositions and methods of preparation thereof are provided. The tissue compositions can be used to treat or regenerate muscle tissue. The compositions can be configured to provide increased strength compared to other muscle matrices.
    Type: Grant
    Filed: January 29, 2018
    Date of Patent: September 7, 2021
    Assignee: LifeCell Corporation
    Inventors: Li Ting Huang, Eric Stec, Nathaniel Bachrach, Hui Xu
  • Tissue matrix materials and enzymatic adhesives
    Patent number: 10940184
    Abstract: The present application relates to use of transglutaminases to treat various tissue matrix products. The methods can include application of a transglutaminase to a partially denatured collagen-containing tissue matrix and implantation of the tissue matrix. The transglutaminase can facilitate adhesion with another collagen-containing tissue matrix, tissue surrounding the tissue matrix after implantation, or both.
    Type: Grant
    Filed: January 29, 2018
    Date of Patent: March 9, 2021
    Assignee: LifeCell Corporation
    Inventors: Eric Stec, Ming F. Pomerleau, Rick T. Owens, Richard Seeman
  • TRANSGLUTAMINASE TREATED PRODUCTS
    Publication number: 20210015970
    Abstract: The present application relates to use of transglutaminases to treat various products, including medical devices such as tissue grafts, tissue matrices or other tissue-derived materials, and synthetics. The transglutaminases can be applied to the medical devices to provide advantages such as adhesion resistance or abrasion resistance.
    Type: Application
    Filed: October 6, 2020
    Publication date: January 21, 2021
    Inventors: Yi Chen, Sean Collins, Li Ting Huang, Eric Stec, Hui Xu
  • COATED POLYMERIC MATERIAL
    Publication number: 20200397943
    Abstract: The present application relates to a polymeric material coating with a combination of acellular tissue matrix particles, transglutaminase, and an at least partially denatured collagen. Methods of producing the coated material and methods of treatment using the coated material are provided.
    Type: Application
    Filed: June 5, 2020
    Publication date: December 24, 2020
    Inventors: Hui Xu, Li Ting Huang, Eric Stec, Ming F. Pomerleau
  • INJECTABLE MESH
    Publication number: 20200384156
    Abstract: The present application relates to injectable tissue products and their production and use thereof. The tissue products include a group of acellular tissue matrix particles, a bioadhesive, and a biocompatible polymer. The tissue products may be used to treat hernia defects.
    Type: Application
    Filed: June 5, 2020
    Publication date: December 10, 2020
    Inventors: Hui Xu, Eric Stec, Ming F. Pomerleau
  • Transglutaminase treated products
    Patent number: 10814033
    Abstract: The present application relates to use of transglutaminases to treat various products, including medical devices such as tissue grafts, tissue matrices or other tissue-derived materials, and synthetics. The transglutaminases can be applied to the medical devices to provide advantages such as adhesion resistance or abrasion resistance.
    Type: Grant
    Filed: August 21, 2019
    Date of Patent: October 27, 2020
    Assignee: LifeCell Corporation
    Inventors: Yi Chen, Sean Collins, Li Ting Huang, Eric Stec, Hui Xu
  • DECELLULARIZED MUSCLE MATRIX
    Publication number: 20200114043
    Abstract: Disclosed herein are muscle implants and methods of making muscle implants comprising one or more decellularized muscle matrices. The muscle matrices can be provided in a particulate form suitable for injection or implantation.
    Type: Application
    Filed: October 10, 2019
    Publication date: April 16, 2020
    Inventors: Hui Xu, Li Ting Huang, Eric Stec
  • TRANSGLUTAMINASE TREATED PRODUCTS
    Publication number: 20190374678
    Abstract: The present application relates to use of transglutaminases to treat various products, including medical devices such as tissue grafts, tissue matrices or other tissue-derived materials, and synthetics. The transglutaminases can be applied to the medical devices to provide advantages such as adhesion resistance or abrasion resistance.
    Type: Application
    Filed: August 21, 2019
    Publication date: December 12, 2019
    Inventors: Yi Chen, Sean Collins, Li Ting Huang, Eric Stec, Hui Xu
  • Transglutaminase treated products
    Patent number: 10413634
    Abstract: The present application relates to use of transglutaminases to treat various products, including medical devices such as tissue grafts, tissue matrices or other tissue-derived materials, and synthetics. The transglutaminases can be applied to the medical devices to provide advantages such as adhesion resistance or abrasion resistance.
    Type: Grant
    Filed: January 29, 2018
    Date of Patent: September 17, 2019
    Assignee: LifeCell Corporation
    Inventors: Yi Chen, Sean Collins, Li Ting Huang, Eric Stec, Hui Xu
  • DEVICES INCLUDING MUSCLE MATRIX AND METHODS OF PRODUCTION AND USE
    Publication number: 20180214603
    Abstract: Tissue compositions and methods of preparation thereof are provided. The tissue compositions can be used to treat or regenerate muscle tissue. The compositions can be configured to provide increased strength compared to other muscle matrices.
    Type: Application
    Filed: January 29, 2018
    Publication date: August 2, 2018
    Inventors: Li Ting Huang, Eric Stec, Nathaniel Bachrach, Hui Xu
  • TRANSGLUTAMINASE TREATED PRODUCTS
    Publication number: 20180214602
    Abstract: The present application relates to use of transglutaminases to treat various products, including medical devices such as tissue grafts, tissue matrices or other tissue-derived materials, and synthetics. The transglutaminases can be applied to the medical devices to provide advantages such as adhesion resistance or abrasion resistance.
    Type: Application
    Filed: January 29, 2018
    Publication date: August 2, 2018
    Applicant: LifeCell Corporation
    Inventors: Yi Chen, Sean Collins, Li Ting Huang, Eric Stec, Hui Xu
  • TISSUE MATRIX MATERIALS AND ENZYMATIC ADHESIVES
    Publication number: 20180214520
    Abstract: The present application relates to use of transglutaminases to treat various tissue matrix products. The methods can include application of a transglutaminase to a partially denatured collagen-containing tissue matrix and implantation of the tissue matrix. The transglutaminase can facilitate adhesion with another collagen-containing tissue matrix, tissue surrounding the tissue matrix after implantation, or both.
    Type: Application
    Filed: January 29, 2018
    Publication date: August 2, 2018
    Applicant: LifeCell Corporation
    Inventors: Eric Stec, Ming F. Pomerleau, Rick T. Owens, Richard Seeman